Blueprint Medicines (BPMC)
(Real Time Quote from BATS)
$89.71 USD
-2.55 (-2.76%)
Updated Apr 25, 2024 10:08 AM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -1.64 |
EPS Last Quarter | -1.82 |
Last EPS Surprise | 10.78% |
ABR | 1.94 |
Earnings ESP
|
16.92% |
---|---|
Current Year | -5.41 |
Next Year | -2.89 |
EPS (TTM) | -8.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 82.58M | 93.65M | 392.41M | 563.15M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 86.70M | 101.90M | 424.60M | 618.20M |
Low Estimate | 78.10M | 90.22M | 371.76M | 504.03M |
Year ago Sales | 63.29M | 57.57M | 249.38M | 392.41M |
Year over Year Growth Est. | 30.47% | 62.67% | 57.35% | 43.51% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.64 | -1.42 | -5.41 | -2.89 |
# of Estimates | 10 | 9 | 10 | 10 |
Most Recent Consensus | -1.80 | -1.56 | -5.97 | -3.05 |
High Estimate | -1.36 | -1.14 | -4.24 | -1.74 |
Low Estimate | -1.80 | -1.63 | -6.35 | -4.30 |
Year ago EPS | -2.15 | -2.19 | -8.37 | -5.41 |
Year over Year Growth Est. | 23.72% | 35.16% | 35.36% | 46.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.64 | -1.42 | -5.41 | -2.89 |
7 Days Ago | -1.65 | -1.43 | -5.42 | -2.92 |
30 Days Ago | -1.65 | -1.43 | -5.42 | -2.95 |
60 Days Ago | -1.67 | -1.47 | -5.58 | -3.14 |
90 Days Ago | -1.74 | -1.45 | -5.44 | -3.08 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.36 | -1.14 | -4.24 | -2.50 |
Zacks Consensus Estimate | -1.64 | -1.42 | -5.41 | -2.89 |
Earnings ESP | 16.92% | 19.72% | 21.67% | 13.61% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.82 | -2.20 | -2.19 | -2.15 | NA |
Estimate | -2.04 | -2.39 | -2.58 | -2.66 | NA |
Difference | 0.22 | 0.19 | 0.39 | 0.51 | 0.33 |
Surprise | 10.78% | 7.95% | 15.12% | 19.17% | 13.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more